Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: J David Smeijer, Donald E Kohan, Peter Rossing, Ricardo Correa-Rotter, Adrian Liew, Sydney C W Tang, Dick de Zeeuw, Ron T Gansevoort, Wenjun Ju, Hiddo J Lambers Heerspink 

Journal title: Cardiovascular Diabetology

Journal number: Sep 16;22(1)

Journal publisher: BioMed Central

Published year: 2023

Published pages: 251

DOI identifier: 10.1186/s12933-023-01964-8

ISSN: 1475-2840